摘要:
                                The major human metabolite of atomoxetine (4-hydroxyatomoxetine) was tested against a panel of receptors and enzymes, and was found to interact with the mu, delta, and kappa-opioid receptors based upon studies involving both binding and functional assays. 4-Hydroxyatomoxetine was determined to be a partial agonist of the K-opioid receptor. (C) 2004 Elsevier Ltd. All rights reserved.